Michail S. Lionakis

Fungal Pathogenesis Unit, National Institute of Allergy and Infectious Diseases, NIH

Affiliated withNational Institute of Allergy and Infectious Diseases, NIH

Research Area

Biography

Michail S. Lionakis has not added Biography.
If you are Michail S. Lionakis and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 242	2013

Other Publications

Article	Year
Pentamidine is active in vitro against Fusarium species. Antimicrobial agents and chemotherapy\| PubMed ID: 14506038	2003
Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity. Diagnostic microbiology and infectious disease\| PubMed ID: 14522515	2003
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole. Antimicrobial agents and chemotherapy\| PubMed ID: 14576123	2003
Glucocorticoids and invasive fungal infections. Lancet\| PubMed ID: 14654323	2003
The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer\| PubMed ID: 14692037	2004
Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus... Antimicrobial agents and chemotherapy\| PubMed ID: 15215099	2004
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 15307028	2004
Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence. The Journal of infectious diseases\| PubMed ID: 15747256	2005
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. The Journal of infectious diseases\| PubMed ID: 15776383	2005
Sinus zygomycosis in a patient receiving voriconazole prophylaxis. British journal of haematology\| PubMed ID: 15801950	2005
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Diagnostic microbiology and infectious disease\| PubMed ID: 15878437	2005
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 15937764	2005
Fusarium infections in critically ill patients. Seminars in respiratory and critical care medicine\| PubMed ID: 16088459	2004
Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initia... Pharmacotherapy\| PubMed ID: 16164392	2005
Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis. Infection and immunity\| PubMed ID: 16239579	2005
Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. Journal of clinical microbiology\| PubMed ID: 16333108	2005
Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis. Antimicrobial agents and chemotherapy\| PubMed ID: 16377700	2006
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species. The Journal of infectious diseases\| PubMed ID: 16518764	2006
Role of mini-host models in the study of medically important fungi. The Lancet infectious diseases\| PubMed ID: 17182343	2007
Malaise, weight loss, pleuritic chest pain and productive cough: what is your call? CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne\| PubMed ID: 18458260	2008
Endocrine and metabolic manifestations of invasive fungal infections and systemic antifungal treatment. Mayo Clinic proceedings. Mayo Clinic\| PubMed ID: 18775205	2008
Organ-specific innate immune responses in a mouse model of invasive candidiasis. Journal of innate immunity\| PubMed ID: 21063074	2011
The growing promise of Toll-deficient Drosophila melanogaster as a model for studying Aspergillus pathogenesis and treatment. Virulence\| PubMed ID: 21178494	2010
Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice. Circulation research\| PubMed ID: 21680896	2011
Drosophila and Galleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology. Virulence\| PubMed ID: 22186764	2011
Drosophila melanogaster as a model organism for invasive aspergillosis. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 22328395	2012
Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due ... Virulence\| PubMed ID: 22546902	2012
Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. PLoS pathogens\| PubMed ID: 22916017	2012
Genetic Susceptibility to Fungal Infections in Humans. Current fungal infection reports\| PubMed ID: 23087779	2012
Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans. PloS one\| PubMed ID: 23144764	2012
Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice. Cardiovascular research\| PubMed ID: 23180724	2013
Candida and host determinants of susceptibility to invasive candidiasis. PLoS pathogens\| PubMed ID: 23300452	2013
CARD9: at the intersection of mucosal and systemic antifungal immunity. Blood\| PubMed ID: 23538230	2013